Servier Pharmaceuticals

Members of #Servier’s Medical Affairs Team were proud to support the next generation of innovators at Nan Fung Life Sciences Real Estate 2nd Annual STEM Education Series in partnership with Science from Scientists! Moments like these remind us of our commitment to advancing #STEAM education. Thank you to everyone who made this inspiring and fun-filled day possible!

We are thrilled to be recognized as a Fierce Pharma 2025 finalist in various categories, in partnership with CultHealth, An Indegene Company.      Annually, the Fierce Pharma Marketing Awards recognize exceptional innovation and strategic achievements within the pharma marketing and advertising community.     We’re honored to be named among industry leaders who have created impactful campaigns to address our most pressing global health challenges. https://lnkd.in/eTGKm2R9

One year ago, #Servier brought the first and only FDA-approved targeted therapy for Grade 2 IDH-mutant glioma to patients in the U.S., marking the first significant treatment breakthrough for this relentless condition in over two decades.     Today, our commitment remains stronger than ever as we continue to drive progress forward for patients and families affected by #glioma and other IDH-mutated cancers. Learn more about our ongoing efforts here: https://lnkd.in/e_i7mBjD

At #Servier, work-life balance isn’t just encouraged, it’s modeled directly by our leaders.     In her latest article, Susan Pandya, Vice President of Clinical Development and Global Oncology at Servier, discusses the importance of taking time to recharge and invest in activities that “bring you back to yourself.”    Check it out! 

As #Servier continues to grow, we’re looking for several talented and purpose-driven individuals to join our #Legal team!       Check out our open #AssociateCounsel and #ContractManager positions and apply here: https://lnkd.in/gRWqxyj9

Happy #NationalInternDay! Today, we’re celebrating the contributions of our summer interns, a group of bright and driven individuals who have brought fresh perspectives and enthusiasm to Servier.     Hear directly from our interns about what it’s been like to work at #Servier this summer.

Have you heard about the V.I.E program?      The V.I.E – or Volontariat International en Entreprise – program is a French program that gives young professionals the chance to work abroad and gain international experience.     At Servier, we’re lucky to host a cohort of V.I.Es in our Boston office. From R&D to legal, communications and public affairs, these professionals are making a true impact – for our business and our culture.       Check out the story here: https://lnkd.in/eb2MWMtr

Positive long-term data from our Phase 3 AML trial were published in Blood Advances. These results are a testament to #Servier’s industry-leading research in IDH-mutated cancers and emphasize the importance of genetic testing to guide treatment selection for #patients.     Read the full announcement here: https://lnkd.in/emeiqQvK

Today, we received a positive #CHMP opinion from the European Medicines Agency for our targeted therapy for Grade 2 IDH-mutant glioma. If approved, this would mark the first significant treatment breakthrough for glioma in over two decades in the EU. This milestone underscores our commitment to providing options for patients and their families and drive progress for all affected by #glioma.    Learn more about this news: https://lnkd.in/eZYFMgqd

Servier teams and their families gathered to enjoy some warm weather fun during our annual summer outing!     Creating opportunities for our employees to connect beyond the workplace is just one of the ways we invest in a people-first culture.    Learn more about the Servier experience: https://lnkd.in/gRWqxyj9